文献速递烧伤创面修复

局部促红细胞生成素治疗眼部化学烧伤后巩膜坏死

Topical erythropoietin for the management of scleral necrosis after ocular chemical burns.
PubMed 文献 · Burns · 2024-04-04

这项研究纳入16例患者18只眼,评估局部促红细胞生成素治疗化学烧伤所致巩膜坏死的疗效。前瞻性组11只眼接受局部促红细胞生成素3000 IU/mL每6小时一次联合标准药物治疗,回顾性历史对照组7只眼仅接受传统治疗。促红细胞生成素组巩膜坏死全部改善,对照组巩膜坏死未改善且需眼表重建。

要点

  • 促红细胞生成素组11只眼在治疗30.7±23.2天后巩膜坏死均改善。
  • 促红细胞生成素组10只眼角膜上皮缺损在用药开始后61.9±50.7天完全愈合。
  • 历史对照组7只眼仅标准药物治疗未改善巩膜坏死,需眼表重建。

核心结论

  • 局部促红细胞生成素对化学烧伤所致巩膜坏死有效,该治疗可使发炎眼避免眼表重建手术。

研究设计与样本

  • 研究纳入16例患者18只眼,均为伤后6周内就诊的化学烧伤所致巩膜坏死。
  • 前瞻性组11只眼接受局部促红细胞生成素3000 IU/mL每6小时一次联合标准药物治疗。
  • 回顾性纳入7例患者7只眼作为历史对照组,接受传统治疗。
  • 主要结局为无血管巩膜病变愈合,次要结局为角膜完全再上皮化。

主要发现

  • 促红细胞生成素组平均年龄39.8±16.2岁,急性化学伤后16.6±15.2天就诊。
  • 促红细胞生成素组所有眼在治疗30.7±23.2天后巩膜坏死改善。
  • 促红细胞生成素组10只眼角膜上皮缺损在用药开始后61.9±50.7天完全愈合。
  • 历史对照组仅标准药物治疗未改善巩膜坏死,需眼表重建,包括结膜前徙1只眼和Tenon囊瓣术6只眼。

临床怎么用

  • 作者认为局部促红细胞生成素可有效处理化学烧伤所致巩膜坏死,并可使发炎眼避免眼表重建手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the efficacy of topical erythropoietin for chemical burn induced scleral necrosis. METHODS: This study included 18 eyes of 16 patients with chemical burn induced scleral necrosis who presented within 6 weeks of the injury. In the prospective arm, 11 eyes received topical erythropoietin, 3000 IU/mL every 6 h, along with standard medical treatment. Retrospectively, we included 7 consecutive eyes of 7 patients who were managed with conventional treatment as historical control group. The main outcome measure was healing of avascular scleral lesions. The secondary outcome measure was complete re-epithelization of cornea. RESULTS: Mean patient age was 39.8 ± 16.2 years in the erythropoietin group, and they presented 16.6 ± 15.2 days after acute chemical injury. Scleral necrosis improved in all eyes after 30.7 ± 23.2 days of treatment with topical erythropoietin. Corneal epithelial defects were completely healed in 10 eyes 61.9 ± 50.7 days after the start of the medication. In comparison, standard medical treatment alone did not improve scleral necrosis in the historical control group, necessitating ocular surface reconstruction including conjunctival advancement (1 eye) and tenonplasty (6 eyes). CONCLUSION: The results of our study showed that topical erythropoietin was effective in the management of chemical burn induced scleral necrosis. This treatment could avoid ocular surface reconstruction procedures in inflamed eyes.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Feizi S, Jafari F, Hooshmandi S, et al. Topical erythropoietin for the management of scleral necrosis after ocular chemical burns. Burns. 2024. PMID: 38604821. doi:10.1016/j.burns.2024.03.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。